Psychological Services Integration in Gynecological Oncology Clinics
NCT ID: NCT03481127
Last Updated: 2019-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
101 participants
INTERVENTIONAL
2018-05-08
2019-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological Interventions for Gynecologic Cancer
NCT01951807
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
NCT01764802
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
NCT03902379
Effect of a Psycho-educational Intervention on Psychological Outcomes of Gynecological Cancer Patients
NCT05965596
Psychosocial Impact of Cancer-Related Female Infertility
NCT00386217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1: Usual Care
-No psychosocial care in clinic
Surveys
* NCCN Distress Thermometer
* PROMIS Depression \& Anxiety
* Quality of Life (SF-12)
* Brief COPE
* Patient awareness and satisfaction survey
Blood draw
* For patients with ovarian, fallopian tube, or primary peritoneal cysts
* Optional
* Enrollment, 3 months after enrollment, and 6 months after enrollment
Fresh tissue from ovary
* For patients with ovarian, fallopian tube, or primary peritoneal cysts
* Optional
* At time of standard of care surgery
Arm 2: Integrated Care
-Those who receive integrated care will receive a one-page care plan completed by Dr. Vanderlan including their scores from screening questionnaires , recommendations for coping strategies and available supportive resources.
Integrated psychological care
Additional possible strategies used may include supportive or validating interventions, increasing/introducing/reinforcing coping strategies, psychoeducation; distress tolerance skills; brief cognitive behavioral therapy; cognitive restructuring; activity scheduling; acceptance; and relaxation/mindfulness.
Surveys
* NCCN Distress Thermometer
* PROMIS Depression \& Anxiety
* Quality of Life (SF-12)
* Brief COPE
* Patient awareness and satisfaction survey
Blood draw
* For patients with ovarian, fallopian tube, or primary peritoneal cysts
* Optional
* Enrollment, 3 months after enrollment, and 6 months after enrollment
Fresh tissue from ovary
* For patients with ovarian, fallopian tube, or primary peritoneal cysts
* Optional
* At time of standard of care surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrated psychological care
Additional possible strategies used may include supportive or validating interventions, increasing/introducing/reinforcing coping strategies, psychoeducation; distress tolerance skills; brief cognitive behavioral therapy; cognitive restructuring; activity scheduling; acceptance; and relaxation/mindfulness.
Surveys
* NCCN Distress Thermometer
* PROMIS Depression \& Anxiety
* Quality of Life (SF-12)
* Brief COPE
* Patient awareness and satisfaction survey
Blood draw
* For patients with ovarian, fallopian tube, or primary peritoneal cysts
* Optional
* Enrollment, 3 months after enrollment, and 6 months after enrollment
Fresh tissue from ovary
* For patients with ovarian, fallopian tube, or primary peritoneal cysts
* Optional
* At time of standard of care surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for an appointment in a gynecologic oncology clinic at the Siteman Cancer Center at the Center for Advanced Medicine or the Women's Tumor Clinic at the Center for Outpatient Health at Barnes-Jewish Hospital
* Patients may or may not have a cancer diagnosis.
* All gynecologic cancer types, histologic grades, primary or recurrent disease.
* Patients actively undergoing treatment or close observation
* Pregnant or lactating patients
* Able to speak and read English
* Able to consent
Exclusion Criteria
* Neoadjuvant chemotherapy
* Treatment within the past month with antidepressant medications that affect serotonin physiology
* Specific histology: low malignant potential tumors, non-epithelial cancer histology.
* Previous cancer diagnosis within the past five years or recurrent cancer
* Regular steroid use in the last month
* Presence of comorbidities with known effects on the immune system (e.g., systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis), congestive heart failure, pregnancy, or stroke within the past six months
* Major surgery in the past month.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barnes-Jewish Hospital
OTHER
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jessica Vanderlan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201711117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.